NovaGo Therapeutics
PrivateLast Round
Series B
Sep 2, 2026
Total Funding Raised
$41M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NovaGo Therapeutics is a biotechnology company that develops human antibody therapeutics to promote nerve growth and regeneration for conditions like spinal cord injury and stroke.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovaGo Therapeutics Comparables
Compare NovaGo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReNetX Bio | 87% | |
| CSPC Pharmaceutical Group Limited | 77% | |
| Axonis Therapeutics | 77% |
NovaGo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 2, 2026 | ||||
| Series A | Mar 4, 2019 | ||||
| Grant | Jan 1, 2015 |
NovaGo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wings for Life Foundation | Series B |
| Wyss Zurich | Grant |
| Pureos Bioventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
$30M round led by Neurimmune AG and Pureos Bioventures.
- Aug 21, 2026
Monthly visitors grew 51% MoM.
Recent news
Latest coverage and updates
- is_developingSep 15, 2026
NovaGo Therapeutics AG is developing antibodies against Nogo-A.
- receives_awardSep 8, 2026
NovaGo Therapeutics AG receives award Strüngmann Award 2025.
- is_developingSep 2, 2026
NovaGo Therapeutics AG is developing anti-Nogo-A pipeline on Sep 2nd '26.
- receives_financingSep 2, 2026
NovaGo Therapeutics AG received financing of $30M in Series B on Sep 2nd '26.
NovaGo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NovaGo Therapeutics's valuation, stock price, and market status.
Is NovaGo Therapeutics a public or private company?
NovaGo Therapeutics is a private company.
What is the current stock price of NovaGo Therapeutics?
NovaGo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is NovaGo Therapeutics worth (valuation)?
Valuation information for NovaGo Therapeutics is not publicly available.
Can I buy NovaGo Therapeutics stock?
NovaGo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NovaGo Therapeutics's last funding round?
Funding round information for NovaGo Therapeutics is not publicly available.
Who are the main investors in NovaGo Therapeutics?
Investor information for NovaGo Therapeutics is not publicly disclosed.
Will NovaGo Therapeutics IPO soon?
No public IPO plans have been announced for NovaGo Therapeutics.
How can I track NovaGo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NovaGo Therapeutics's secondary market activity and sign up for updates.